Nordea Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.7M | Buy |
|
|||||
|
2025
Q2 | $6.72M | Buy |
|
|||||
|
2025
Q1 | $6.17M | Buy |
|
|||||
|
2024
Q4 | $6.25M | Buy |
|
|||||
|
2024
Q3 | $5.48M | Sell |
|
|||||
|
2024
Q2 | $4.87M | Sell |
|
|||||
|
2024
Q1 | $4.94M | Sell |
|
|||||
|
2023
Q4 | $4.93M | Sell |
|
|||||
|
2023
Q3 | $4.39M | Sell |
|
|||||
|
2023
Q2 | $5.27M | Buy |
|
|||||
|
2023
Q1 | $5.18M | Sell |
|
|||||
|
2022
Q4 | $4.88M | Sell |
|
|||||
|
2022
Q3 | $6.1M | Sell |
|
|||||
|
2022
Q2 | $6.09M | Sell |
|
|||||
|
2022
Q1 | $8.46M | Buy |
|
|||||
|
2021
Q4 | $11.2M | Sell |
|
|||||
|
2021
Q3 | $10.1M | Sell |
|
|||||
|
2021
Q2 | $9.59M | Buy |
|
|||||
|
2021
Q1 | $9.96M | Sell |
|
|||||
|
2020
Q4 | $6.58M | Buy |
|
|||||
|
2020
Q3 | $4.07M | Sell |
|
|||||
|
2020
Q2 | $9.42M | Buy |
|
|||||
|
2020
Q1 | $3.03M | Buy |
|
|||||
|
2019
Q4 | $4.14M | Buy |
|
|||||
|
2019
Q3 | $3.84M | Buy |
|
|||||
|
2019
Q2 | $2.94M | Buy |
|
|||||
|
2019
Q1 | $2.23M | Sell |
|
|||||
|
2018
Q4 | $2.52M | Sell |
|
|||||
|
2018
Q3 | $5.11M | Buy |
|
|||||
|
2018
Q2 | $3.31M | Sell |
|
|||||
|
2018
Q1 | $3.3M | Buy |
|
|||||
|
2017
Q4 | $2.5M | Buy |
|
|||||
|
2017
Q3 | $2.35M | Buy |
|
|||||
|
2017
Q2 | $2.04M | Buy |
|
|||||
|
2017
Q1 | $1.55M | Buy |
|
|||||
|
2016
Q4 | $1.15M | Buy |
|
|||||
|
2016
Q3 | $1.08M | Buy |
|
|||||
|
2016
Q2 | $613K | Buy |
|